デフォルト表紙
市場調査レポート
商品コード
1769626

インテリジェント薬の世界市場レポート2025

Intelligent Pills Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
インテリジェント薬の世界市場レポート2025
出版日: 2025年07月07日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

インテリジェント薬市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR13.1%で135億5,000万米ドルに成長します。予測期間の成長は、リアルタイムのヘルスデータに対する需要の増加、医療モノのインターネット(IoMT)の採用拡大、健康意識の高い消費者の増加、ヘルスケアデータ管理機能の強化、遠隔医療の利用拡大などに起因すると考えられます。予測期間中に予想される主な動向には、人工知能を搭載した錠剤の開発、自己調節錠剤の出現、モバイルヘルスアプリケーションとの統合、ウェアラブルデバイスとの接続、バイオセンシング技術の進歩などがあります。

生活習慣関連疾患の有病率の増加は、今後数年間のインテリジェント薬市場の成長を促進すると予想されます。生活習慣関連疾患は、個人の日々の習慣、行動、ライフスタイルの選択によって大きく引き起こされたり、影響を受けたりする非伝染性疾患です。これらの疾患の増加は主に不健康な食事パターンに起因しており、肥満、心臓病、糖尿病、その他の慢性疾患などの症状を引き起こします。インテリジェント薬は、リアルタイムの健康モニタリング、データに基づく洞察の提供、服薬アドヒアランスの向上、治療結果の改善により、ライフスタイルに関連する疾患の個別化治療をサポートします。例えば、2023年9月、米国を拠点とする政府機関である疾病対策予防センター(CDC)は、2022年には成人の肥満率が35%以上となる州が22州となり、2021年の19州から増加したと報告しました。したがって、生活習慣関連疾患の発生率の増加がインテリジェント薬市場の拡大に寄与しています。

インテリジェント薬市場の主要企業は、患者のモニタリングを改善し、服薬アドヒアランスを高めるために、デジタルヘルス製品などの技術的に高度なソリューションの開発に注力しています。デジタルヘルス製品には、モバイルヘルスアプリケーション、ウェアラブルデバイス、スマートピル、遠隔医療システムなど、テクノロジーを駆使したツールやプラットフォームが含まれ、リアルタイムのモニタリング、管理、健康成果の向上をサポートします。例えば、2022年9月、アイルランドを拠点とする治療会社ヘルスビーコンplcは、複雑な錠剤習慣を持つ患者の服薬管理を改善するHBスマート錠剤管理システムを発売しました。このシステムは、服薬リマインダー、詰め替え通知、服薬アドヒアランスを確保するための錠剤容器の画像キャプチャ、より効果的な服薬管理をサポートするための患者と医療提供者の双方に対する実用的な洞察などの機能を提供します。このシステムは、患者が複雑な服薬スケジュールを守れるよう特別に設計されており、服用漏れを最小限に抑え、治療成績を向上させます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界のインテリジェント薬:PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界のインテリジェント薬市場:成長率分析
  • 世界のインテリジェント薬市場の実績:規模と成長, 2019-2024
  • 世界のインテリジェント薬市場の予測:規模と成長, 2024-2029, 2034F
  • 世界のインテリジェント薬:総潜在市場規模(TAM)

第6章 市場セグメンテーション

  • 世界のインテリジェント薬市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 潜在性消化管出血
  • クローン病
  • 小腸腫瘍
  • セリアック病
  • 遺伝性ポリポーシス症候群
  • 神経疾患
  • 世界のインテリジェント薬市場対象エリア別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 食道
  • 小腸
  • 大腸
  • 世界のインテリジェント薬市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • カプセル内視鏡検査
  • ドラッグデリバリー
  • 患者モニタリング
  • 世界のインテリジェント薬市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院薬局
  • クリニック
  • 調査機関
  • 在宅ヘルスケア
  • 世界のインテリジェント薬市場潜在性消化管出血の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 隠れた消化管出血の検出
  • 潜血の非侵襲的診断
  • 世界のインテリジェント薬市場クローン病の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病気の進行のモニタリング
  • 腸の炎症の評価
  • 世界のインテリジェント薬市場小腸腫瘍の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 小腸における腫瘍の同定
  • 腫瘍のモニタリングと診断
  • 世界のインテリジェント薬市場セリアック病の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • グルテンによる腸内損傷の検出
  • グルテンフリー食の遵守状況のモニタリング
  • 世界のインテリジェント薬市場遺伝性ポリポーシス症候群の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 消化管ポリープの検出
  • 遺伝性ポリポーシスのリスク評価とモニタリング
  • 世界のインテリジェント薬市場神経疾患の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 腸と脳の相互作用のモニタリング
  • 神経疾患における胃腸症状の診断

第7章 地域別・国別分析

  • 世界のインテリジェント薬市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のインテリジェント薬市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • インテリジェント薬市場:競合情勢
  • インテリジェント薬市場:企業プロファイル
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • FUJIFILM Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Olympus Corporation
  • Lloyds Pharmacy Limited
  • STRATACACHE Inc.
  • Check-Cap Ltd.
  • Proteus Digital Health Inc.
  • CapsoVision Inc.
  • Medisafe Inc.
  • IntroMedic Co. Ltd.
  • Jinshan Science And Technology(Group)Co. Ltd.
  • Innurvation Inc.
  • AARDEX Group SA
  • BodyCap SAS
  • AnX Robotica Corp.
  • EtectRx Inc.
  • Given Imaging Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • インテリジェント薬市場2029:新たな機会を提供する国
  • インテリジェント薬市場2029:新たな機会を提供するセグメント
  • インテリジェント薬市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r35941

Intelligent pills, often referred to as smart pills, are ingestible devices equipped with sensors and wireless technology designed to monitor and transmit data from inside the body. These pills serve medical purposes, including monitoring patient adherence, diagnosing medical conditions, and delivering targeted drug treatments.

The primary types of intelligent pills address conditions such as occult gastrointestinal (GI) bleeding, Crohn's disease, small bowel tumors, celiac disease, inherited polyposis syndromes, and neurological disorders. Occult GI bleeding involves internal bleeding in the digestive system that is not visibly apparent and is typically detected through medical testing. These pills are intended for use in areas including the esophagus, stomach, small intestine, and large intestine. They are applied in procedures such as capsule endoscopy, drug administration, and patient monitoring, and are utilized by various end users including hospital pharmacies, clinics, research institutions, and home healthcare providers.

The intelligent pills market research report is one of a series of new reports from The Business Research Company that provides intelligent pills market statistics, including the intelligent pills industry's global market size, regional shares, competitors with the intelligent pills market share, detailed intelligent pills market segments, market trends and opportunities, and any further data you may need to thrive in the intelligent pills market. These intelligent pills market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The intelligent pills market size has grown rapidly in recent years. It will grow from $7.31 billion in 2024 to $8.29 billion in 2025 at a compound annual growth rate (CAGR) of 13.4%. The growth during the historic period can be credited to the rising demand for personalized medicine, the increased adoption of smart healthcare devices, the growing incidence of chronic diseases, greater investments in digital healthcare technologies, and the heightened need for remote patient monitoring.

The intelligent pills market size is expected to see rapid growth in the next few years. It will grow to $13.55 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to the increasing demand for real-time health data, growing adoption of the Internet of Medical Things (IoMT), a rising number of health-conscious consumers, enhanced capabilities in healthcare data management, and the expanding use of telemedicine. Key trends expected during the forecast period include the development of artificial intelligence-powered pills, the emergence of self-regulating pills, integration with mobile health applications, connectivity with wearable devices, and advancements in bio-sensing technology.

The increasing prevalence of lifestyle-related disorders is expected to drive the growth of the intelligent pills market in the coming years. Lifestyle-related disorders are non-communicable diseases largely caused or influenced by individuals' daily habits, behaviors, and lifestyle choices. The rise in these disorders is mainly attributed to unhealthy dietary patterns, which lead to conditions such as obesity, heart disease, diabetes, and other chronic illnesses. Intelligent pills support personalized treatment for lifestyle-related conditions by enabling real-time health monitoring, offering data-driven insights, enhancing medication adherence, and improving therapeutic outcomes. For example, in September 2023, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that in 2022, 22 states had an adult obesity rate of 35% or higher, up from 19 states in 2021. Hence, the growing incidence of lifestyle-related disorders is contributing to the expansion of the intelligent pills market.

Leading companies in the intelligent pills market are concentrating on the development of technologically advanced solutions, such as digital health products, to improve patient monitoring and boost medication adherence. Digital health products encompass technology-driven tools and platforms-including mobile health applications, wearable devices, smart pills, and telemedicine systems-that support real-time monitoring, management, and enhancement of health outcomes. For example, in September 2022, HealthBeacon plc, an Ireland-based therapeutics company, launched the HB Smart Pills Management System to improve medication management for patients with complex pill routines. This system provides features such as medication reminders, refill notifications, image capture of pill containers to ensure adherence, and actionable insights for both patients and healthcare providers to support more effective medication management. It is specifically designed to help patients follow complicated medication schedules, thereby minimizing missed doses and enhancing treatment outcomes.

In April 2022, AARDEX Group, a digital health company based in Belgium, formed a partnership with etectRx Inc. to combine their digital medication adherence technologies, enabling real-time tracking of pill ingestion. The goal of this collaboration is to enhance adherence monitoring in clinical trials by integrating AARDEX's analytics software with etectRx's ingestible sensor, delivering real-time, objective data to improve patient outcomes. etectRx Inc. is a U.S.-based digital health company that specializes in intelligent pills.

Major players in the intelligent pills market are Medtronic plc, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Otsuka Pharmaceutical Co. Ltd., Lonza Group AG, Olympus Corporation, Lloyds Pharmacy Limited, STRATACACHE Inc., Check-Cap Ltd., Proteus Digital Health Inc., CapsoVision Inc., Medisafe Inc., IntroMedic Co. Ltd., Jinshan Science And Technology (Group) Co. Ltd., Innurvation Inc., AARDEX Group SA, BodyCap SAS, AnX Robotica Corp., EtectRx Inc., and Given Imaging Ltd.

North America was the largest region in the intelligent pills market in 2024. The regions covered in intelligent pills report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the intelligent pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intelligent pills market consists of revenues earned by entities by providing services such as patient and treatment management, brainstorm-as-a-service, precision pitch crafting, and cyber health checks. The market value includes the value of related goods sold by the service provider or included within the service offering. The intelligent pills market also includes sales of ingestible sensors, pH-sensitive capsules, temperature-monitoring pills, targeted drug delivery capsules, and capsules with wireless communication capabilities. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intelligent Pills Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intelligent pills market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intelligent pills ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intelligent pills market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Occult GI Bleeding; Chron's Disease; Small Bowel Tumors; Celiac Disease; Inherited Polyposis Syndromes; Neurological Disorder
  • 2) By Target Area: Esophagus; Stomach; Small Intestine; Large Intestine
  • 3) By Application: Capsule Endoscopy; Drug Delivery; Patient Monitoring
  • 4) By End-User: Hospital Pharmacy; Clinics; Research Institutes; Home Healthcare

Subsegments

  • 1) By Occult GI Bleeding: Detection Of Hidden Gastrointestinal Bleeding; Non-Invasive Diagnosis Of Occult Blood Loss
  • 2) By Crohn's Disease: Monitoring Disease Progression; Assessment Of Intestinal Inflammation
  • 3) By Small Bowel Tumors: Tumor Identification In The Small Intestine; Tumor Monitoring And Diagnosis
  • 4) By Celiac Disease: Detection Of Gluten-Induced Damage In The Intestine; Monitoring Adherence To Gluten-Free Diet
  • 5) By Inherited Polyposis Syndromes: Detection Of Polyps In The Gastrointestinal Tract; Risk Assessment And Monitoring For Genetic Polyposis
  • 6) By Neurological Disorders: Monitoring Gut-Brain Interactions; Diagnosis Of Gastrointestinal Symptoms In Neurological Diseases
  • Companies Mentioned: Medtronic plc; FUJIFILM Holdings Corporation; Koninklijke Philips N.V.; Otsuka Pharmaceutical Co. Ltd.; Lonza Group AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intelligent Pills Market Characteristics

3. Intelligent Pills Market Trends And Strategies

4. Intelligent Pills Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Intelligent Pills Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Intelligent Pills PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Intelligent Pills Market Growth Rate Analysis
  • 5.4. Global Intelligent Pills Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Intelligent Pills Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Intelligent Pills Total Addressable Market (TAM)

6. Intelligent Pills Market Segmentation

  • 6.1. Global Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Occult GI Bleeding
  • Chron's Disease
  • Small Bowel Tumors
  • Celiac Disease
  • Inherited Polyposis Syndromes
  • Neurological Disorder
  • 6.2. Global Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Esophagus
  • Stomach
  • Small Intestine
  • Large Intestine
  • 6.3. Global Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Capsule Endoscopy
  • Drug Delivery
  • Patient Monitoring
  • 6.4. Global Intelligent Pills Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacy
  • Clinics
  • Research Institutes
  • Home Healthcare
  • 6.5. Global Intelligent Pills Market, Sub-Segmentation Of Occult GI Bleeding, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Detection Of Hidden Gastrointestinal Bleeding
  • Non-Invasive Diagnosis Of Occult Blood Loss
  • 6.6. Global Intelligent Pills Market, Sub-Segmentation Of Crohn's Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monitoring Disease Progression
  • Assessment Of Intestinal Inflammation
  • 6.7. Global Intelligent Pills Market, Sub-Segmentation Of Small Bowel Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tumor Identification In The Small Intestine
  • Tumor Monitoring And Diagnosis
  • 6.8. Global Intelligent Pills Market, Sub-Segmentation Of Celiac Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Detection Of Gluten-Induced Damage In The Intestine
  • Monitoring Adherence To Gluten-Free Diet
  • 6.9. Global Intelligent Pills Market, Sub-Segmentation Of Inherited Polyposis Syndromes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Detection Of Polyps In The Gastrointestinal Tract
  • Risk Assessment And Monitoring For Genetic Polyposis
  • 6.10. Global Intelligent Pills Market, Sub-Segmentation Of Neurological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monitoring Gut-Brain Interactions
  • Diagnosis Of Gastrointestinal Symptoms In Neurological Diseases

7. Intelligent Pills Market Regional And Country Analysis

  • 7.1. Global Intelligent Pills Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Intelligent Pills Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intelligent Pills Market

  • 8.1. Asia-Pacific Intelligent Pills Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intelligent Pills Market

  • 9.1. China Intelligent Pills Market Overview
  • 9.2. China Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intelligent Pills Market

  • 10.1. India Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intelligent Pills Market

  • 11.1. Japan Intelligent Pills Market Overview
  • 11.2. Japan Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intelligent Pills Market

  • 12.1. Australia Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intelligent Pills Market

  • 13.1. Indonesia Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intelligent Pills Market

  • 14.1. South Korea Intelligent Pills Market Overview
  • 14.2. South Korea Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intelligent Pills Market

  • 15.1. Western Europe Intelligent Pills Market Overview
  • 15.2. Western Europe Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intelligent Pills Market

  • 16.1. UK Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intelligent Pills Market

  • 17.1. Germany Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intelligent Pills Market

  • 18.1. France Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intelligent Pills Market

  • 19.1. Italy Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intelligent Pills Market

  • 20.1. Spain Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intelligent Pills Market

  • 21.1. Eastern Europe Intelligent Pills Market Overview
  • 21.2. Eastern Europe Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intelligent Pills Market

  • 22.1. Russia Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intelligent Pills Market

  • 23.1. North America Intelligent Pills Market Overview
  • 23.2. North America Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intelligent Pills Market

  • 24.1. USA Intelligent Pills Market Overview
  • 24.2. USA Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intelligent Pills Market

  • 25.1. Canada Intelligent Pills Market Overview
  • 25.2. Canada Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intelligent Pills Market

  • 26.1. South America Intelligent Pills Market Overview
  • 26.2. South America Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intelligent Pills Market

  • 27.1. Brazil Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intelligent Pills Market

  • 28.1. Middle East Intelligent Pills Market Overview
  • 28.2. Middle East Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intelligent Pills Market

  • 29.1. Africa Intelligent Pills Market Overview
  • 29.2. Africa Intelligent Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Intelligent Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Intelligent Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intelligent Pills Market Competitive Landscape And Company Profiles

  • 30.1. Intelligent Pills Market Competitive Landscape
  • 30.2. Intelligent Pills Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. FUJIFILM Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

31. Intelligent Pills Market Other Major And Innovative Companies

  • 31.1. Olympus Corporation
  • 31.2. Lloyds Pharmacy Limited
  • 31.3. STRATACACHE Inc.
  • 31.4. Check-Cap Ltd.
  • 31.5. Proteus Digital Health Inc.
  • 31.6. CapsoVision Inc.
  • 31.7. Medisafe Inc.
  • 31.8. IntroMedic Co. Ltd.
  • 31.9. Jinshan Science And Technology (Group) Co. Ltd.
  • 31.10. Innurvation Inc.
  • 31.11. AARDEX Group SA
  • 31.12. BodyCap SAS
  • 31.13. AnX Robotica Corp.
  • 31.14. EtectRx Inc.
  • 31.15. Given Imaging Ltd.

32. Global Intelligent Pills Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intelligent Pills Market

34. Recent Developments In The Intelligent Pills Market

35. Intelligent Pills Market High Potential Countries, Segments and Strategies

  • 35.1 Intelligent Pills Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Intelligent Pills Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Intelligent Pills Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer